Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.
Saved in:
| Title: | Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma. |
|---|---|
| Authors: | Zhou, Hongmei1 (AUTHOR), Zhang, Min1 (AUTHOR), Jin, Yi1 (AUTHOR), Lang, Xianghua1 (AUTHOR) langlingyufanyeah@163.com |
| Source: | Hematology. Dec2025, Vol. 30 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189876812 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhou%2C+Hongmei%22">Zhou, Hongmei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Min%22">Zhang, Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jin%2C+Yi%22">Jin, Yi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lang%2C+Xianghua%22">Lang, Xianghua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> langlingyufanyeah@163.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Hematology%22">Hematology</searchLink>. Dec2025, Vol. 30 Issue 1, p1-12. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189876812 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/16078454.2025.2532893 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 1 Titles: – TitleFull: Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhou, Hongmei – PersonEntity: Name: NameFull: Zhang, Min – PersonEntity: Name: NameFull: Jin, Yi – PersonEntity: Name: NameFull: Lang, Xianghua IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 10245332 Numbering: – Type: volume Value: 30 – Type: issue Value: 1 Titles: – TitleFull: Hematology Type: main |
| ResultId | 1 |